![Biomedicines | Free Full-Text | Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention Biomedicines | Free Full-Text | Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention](https://www.mdpi.com/biomedicines/biomedicines-10-00651/article_deploy/html/images/biomedicines-10-00651-g001.png)
Biomedicines | Free Full-Text | Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention
![Biomedicines | Free Full-Text | TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy Biomedicines | Free Full-Text | TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy](https://www.mdpi.com/biomedicines/biomedicines-09-00876/article_deploy/html/images/biomedicines-09-00876-g001.png)
Biomedicines | Free Full-Text | TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
![Table 1 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar Table 1 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5582615f848e686710455b6e112e876e1ab5fb5a/2-Table1-1.png)
Table 1 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar
![Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer | Breast Cancer Research and Treatment Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer | Breast Cancer Research and Treatment](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-019-05378-7/MediaObjects/10549_2019_5378_Fig1_HTML.png)
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer | Breast Cancer Research and Treatment
![Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses | npj Breast Cancer Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-019-0116-8/MediaObjects/41523_2019_116_Fig6_HTML.png)
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses | npj Breast Cancer
![A Comparison Study of Molecular Classification of Primary Invasive Breast Carcinoma and Corresponding Metastatic Carcinoma in Axillary Lymph Nodes by Immunohistochemistry | Asian Archives of Pathology A Comparison Study of Molecular Classification of Primary Invasive Breast Carcinoma and Corresponding Metastatic Carcinoma in Axillary Lymph Nodes by Immunohistochemistry | Asian Archives of Pathology](https://www.asianarchpath.com/storage/AAP_Original_2_V2N3_2020/AAP_Original_2_V2N3_2020_1.png)
A Comparison Study of Molecular Classification of Primary Invasive Breast Carcinoma and Corresponding Metastatic Carcinoma in Axillary Lymph Nodes by Immunohistochemistry | Asian Archives of Pathology
![Table 2 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar Table 2 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5582615f848e686710455b6e112e876e1ab5fb5a/3-Table2-1.png)
Table 2 from Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. | Semantic Scholar
![Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression | npj Breast Cancer Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00345-2/MediaObjects/41523_2021_345_Fig1_HTML.png)